CrossrefInfokarte
Is It Better to Use Ipilimumab Combined With a PD-1 Inhibitor or a PD-1 Inhibitor Alone as Initial Immunotherapy in Patients With Metastatic Melanoma?
Clinical Skin Cancer · 2017-12 · 2 (1-2) · 10-17
DOI: 10.1016/j.clsc.2017.06.003 ↗Abstract
Kein Abstract verfügbar.
EUVIMED